Cellipont Bioservices' Texas Facility Has Supported Six Client Projects Expected to Reach IND Submission in 2026
THE WOODLANDS, Texas, Sept. 3, 2026 /PRNewswire/ -- Cellipont Bioservices, a cell therapy contract development and manufacturing organization, today announced that its Texas facility has supported six client projects to date that are expected to reach Investigational New Drug application...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.